BIOACTIVE CONSTITUENTS OF SOPHORA MOLLIS AND THEIR POTENTIAL ROLE IN CLINICAL PHARMACY AND PHYSIOTHERAPY-BASED MANAGEMENT OF INFLAMMATORY CONDITIONS. FMHR 2026, 4 (6), 3335-3350.